Since launching its biotech campaign in September 2000, the Free State of Saxony has become one of the most dynamic life sciences regions in Germany – and has now set its sights on Europe. New branches of existing companies and entirely new businesses are creating a critical mass of research and business, particularly around the start-up centers of Leipzig and Dresden. The result is the sustainable growth of Saxony as a future-oriented life sciences location with plenty of untapped potential.
As a cross-sectional technology, biotechnology is of great importance for a large number of high-tech industries and more and more sectors are using biotechnological processes.
Meanwhile, there are 50 dedicated biotechnology companies in Saxony that are primarily engaged in red biotechnology. However, biotechnology is also closely linked to various other industries and creates new application possibilities here. For example, there are more than 200 associated companies in Saxony that are not directly involved in biotechnology, but contribute significantly to the added value of biotechnology.
The life sciences with biotechnology as a driving force have gained scientific and economic importance in Saxony and form an important pillar of the high-tech location with significant future potential.
Medical technology is one of the key industries of the future. In Saxony, the industry is characterized by small and medium-sized companies and is subject to a high level of dynamism. Around 230 medical technology companies produce and research in Saxony. These range from equipment, innovative diagnostic procedures and devices to consumables for the medical sector. In addition, there are a large number of research and incubation centers where innovations for tomorrow's challenges are developed and marketed today.